Publications by authors named "Kenya Ochi"

Claim this Profile
A
A multicenter retrospective study of nivolumab monotherapy in previously treated metastatic renal cell carcinoma patients: interim analysis of Japanese real-world data.
Nobuyuki Hinata, Junji Yonese, Satoru Masui, Yasutomo Nakai, Suguru Shirotake, Kenya Ochi

Int J Clin Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns and outcomes in patients with unresectable or metastatic renal cell carcinoma in Japan.
Kenichi Harada, Masahiro Nozawa, Motohide Uemura, Katsunori Tatsugami, Takahiro Osawa, Kenya Ochi

Int J Urol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic Treatment Patterns With Advanced or Recurrent Non-small Cell Lung Cancer in Japan: A Retrospective Hospital Administrative Database Study.
Feng Wang, Sari Mishina, Shinji Takai, T Kim Le, Kenya Ochi

Clin Ther· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of DPP-IV inhibitors lacking the electrophilic nitrile group.
Takashi Kondo, Takahiro Nekado, Isamu Sugimoto, Kenya Ochi, Shigeyuki Takai

Bioorg Med Chem· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of long-acting N-(cyanomethyl)-N-alkyl-L-prolinamide inhibitors of dipeptidyl peptidase IV.
Takashi Kondo, Takahiro Nekado, Isamu Sugimoto, Kenya Ochi, Shigeyuki Takai

Bioorg Med Chem· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of long-acting inhibitors of dipeptidyl peptidase IV.
Takashi Kondo, Isamu Sugimoto, Takahiro Nekado, Kenya Ochi, Tazumi Ohtani

Bioorg Med Chem· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of new potent dipeptidyl peptidase IV inhibitors with enhanced ex vivo duration.
Takashi Kondo, Takahiro Nekado, Isamu Sugimoto, Kenya Ochi, Shigeyuki Takai

Bioorg Med Chem· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis